InvestorsHub Logo
Followers 20
Posts 2394
Boards Moderated 0
Alias Born 01/28/2012

Re: eicoman post# 8139

Friday, 07/05/2013 2:59:45 PM

Friday, July 05, 2013 2:59:45 PM

Post# of 30393
Any significant partnership with a big player will refute AF, either for Vitaros or Femprox. The problem with our citing of major partners like "Takeda, Novartis, Bracco and Abbott" is that none of them has moved recently. For the first three, we probably won't hear anything until one of them gets market authorization. And the last, and maybe only, time we have heard from Abbott is when they paid up $2.5M for the delivery of an "acceptable" batch of Vitaros last fall.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News